STOCK TITAN

ClearPoint Neuro Inc - CLPT STOCK NEWS

Welcome to our dedicated news page for ClearPoint Neuro (Ticker: CLPT), a resource for investors and traders seeking the latest updates and insights on ClearPoint Neuro.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ClearPoint Neuro's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ClearPoint Neuro's position in the market.

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-16.58%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.36%
Tags
partnership
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.38%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.51%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.5%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.9%
Tags
management
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.69%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.1%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.9%
Tags
conferences
ClearPoint Neuro Inc

Nasdaq:CLPT

CLPT Rankings

CLPT Stock Data

157.27M
24.73M
7.6%
29.16%
4.72%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States
Solana Beach

About CLPT

we are a medical device company that develops and commercializes innovative platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging, or mri, guidance. since our inception in 1998, we have focused on research and product development in the field of interventional mri. from 1998 to 2002, we deployed significant resources to fund our efforts to develop the foundational capabilities for enabling mri-guided interventions and to build an intellectual property position. in 2003, our focus shifted to identifying and building out commercial applications for the technologies we developed in prior years. we have two product platforms. our clearpoint® system, which is in commercial use in the united states, is used to perform minimally invasive surgical procedures in the brain. our cleartrace system, which is still in development, will be used to perform minimally invasive surgical procedures in the heart. bot